Liposome and Proliposome Based Drug Delivery

by ,

Write The First Customer Review
Show Synopsis

A promising strategy to overcome these problems involves the development of suitable drug carrier system. The In vivo fate of the drug is no longer mainly determined by the properties of the drug, but by the carrier system, which permit a controlled and localized release of the active drug according to the specific needs of the therapy. The size of the carrier depends on the desired route of administration and ranges from few nanometers to micrometers (implants). Implants and microparticles are too large for drug targeting ...

Filter Results
Shipping
Item Condition
Seller Rating
Other Options
Change Currency

Customer Reviews

Write a Review


This item doesn't have extra editions

loading